NEW YORK STATE COMMON RETIREMENT FUND - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$3,729
+16.0%
3,796,000
+21.1%
0.01%
+25.0%
Q1 2023$3,215
-29.1%
3,134,000
-26.7%
0.00%
-33.3%
Q4 2022$4,536
-99.9%
4,274,000
-21.1%
0.01%
-25.0%
Q3 2022$5,364,000
+0.1%
5,414,0000.0%0.01%
+14.3%
Q2 2022$5,360,000
-9.8%
5,414,000
-8.9%
0.01%
+16.7%
Q1 2022$5,942,000
-4.4%
5,945,0000.0%0.01%0.0%
Q4 2021$6,216,000
-17.6%
5,945,000
-19.4%
0.01%
-25.0%
Q3 2021$7,545,000
-1.3%
7,374,0000.0%0.01%0.0%
Q2 2021$7,642,000
-11.3%
7,374,000
-13.4%
0.01%
-20.0%
Q1 2021$8,616,000
-30.9%
8,515,000
-26.8%
0.01%
-28.6%
Q4 2020$12,477,000
+37.3%
11,627,000
+34.3%
0.01%
+27.3%
Q3 2020$9,085,000
+57.3%
8,658,000
+83.2%
0.01%
+57.1%
Q2 2020$5,775,000
-39.7%
4,726,000
-48.3%
0.01%
-50.0%
Q1 2020$9,584,000
-0.8%
9,146,0000.0%0.01%
+27.3%
Q4 2019$9,663,000
+7.5%
9,146,0000.0%0.01%0.0%
Q3 2019$8,990,000
-5.3%
9,146,0000.0%0.01%
-8.3%
Q2 2019$9,495,000
+10.1%
9,146,000
+8.5%
0.01%
+9.1%
Q1 2019$8,626,000
-3.8%
8,431,000
-6.5%
0.01%
-15.4%
Q4 2018$8,966,0009,016,0000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 53,670$57,726,0003.34%
SHENKMAN CAPITAL MANAGEMENT INC 26,959,000$29,149,0003.04%
ADVENT CAPITAL MANAGEMENT /DE/ 84,134,000$90,539,0001.93%
Cheyne Capital Management (UK) LLP 3,220,000$3,452,0001.75%
PFM Health Sciences, LP 40,300,000$43,210,0001.52%
Sonora Investment Management, LLC 6,370,000$6,807,0000.56%
MACKAY SHIELDS LLC 66,018,000$70,980,0000.49%
ZAZOVE ASSOCIATES LLC 1,500,000$1,608,0000.20%
IRON Financial LLC 275,000$295,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$3,216,0000.08%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders